Rise Advisors’s Alignment Healthcare ALHC Stock Holding History

Rise Advisors’s Portfolio ALHC Stock Details ALHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75	Closed	-$1.31K	–	149
2025 Q3	$1.31K	Buy	+75	New	+$1.11K	﹤0.01%	1238

Other funds holding ALHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rise Advisors's ALHC Position: Q4 2025 in Review

Rise Advisors sold out of Alignment Healthcare (ALHC) in Q4 2025, closing a stake of 75 shares — an estimated $1.31K sold.

Rise Advisors first reported a position in ALHC in Q3 2025 and held it in 1 quarter. The position peaked at $1.31K in Q3 2025. 263 funds tracked by Wall St. Rank hold ALHC as of Q4 2025.

Rise Advisors reported no remaining Alignment Healthcare position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 75 Alignment Healthcare shares in Q4 2025, an estimated $1.31K.
Rise Advisors first reported a position in Alignment Healthcare in Q3 2025 and held it in 1 quarter.
Rise Advisors's Alignment Healthcare position peaked at $1.31K in Q3 2025.
263 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.